Global Self Injection Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
According to our (Global Info Research) latest study, the global Self Injection Device market size was valued at USD 9034.3 million in 2022 and is forecast to a readjusted size of USD 12210 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.
Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
This report is a detailed and comprehensive analysis for global Self Injection Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Self Injection Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Self Injection Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Self Injection Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Self Injection Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Self Injection Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Self Injection Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Mylan, Pfizer, Sanofi and BD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Self Injection Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Reusable Self Injection Device
    Disposable Self Injection Device
Market segment by Application
    Insulin Injection
    Epinephrine Injection
    Others
Major players covered
    Novo Nordisk
    Mylan
    Pfizer
    Sanofi
    BD
    Eli Lilly
    Gerresheimer
    Dongbao
    Ypsomed
    Owen Mumford
    Antares Pharma
    Haselmeier
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Self Injection Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Self Injection Device, with price, sales, revenue and global market share of Self Injection Device from 2018 to 2023.
Chapter 3, the Self Injection Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Self Injection Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Self Injection Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Self Injection Device.
Chapter 14 and 15, to describe Self Injection Device sales channel, distributors, customers, research findings and conclusion.